Please login to the form below

Not currently logged in

Pfizer launches Latin American vaccine education campaign

Public-facing pneumococcal disease campaign will cover 14 countries in the region

Pfizer is working with Miami-based communications agency Jeffrey Group on a public health education campaign to raise awareness of pneumococcal disease in 14 Latin American countries.

The US pharma company aims to educate Latin Americans about vaccines for adults over the age of 50 suffering from pneumococcal disease.

"With approximately 125,000 Latin Americans over the age of 50 dying each year from pneumococcal disease, we felt it was critical to lead an aggressive awareness campaign to help educate the public about their prevention options," said Mark Partridge, Pfizer's regional marketing head of vaccines for Latin America.

"With that in mind, it was just as critical to choose the right partner with demonstrated healthcare expertise in the complex Latin American regulatory environment."

Headquartered in Miami, the Jeffrey Group has offices in New York, Mexico City, Sao Paulo and Buenos Aires and specialises in helping businesses engage Latin audiences.

The campaign will focuses on awareness and prevention, taking an unbranded approach and using a trilingual website, social media management, testimonial videos, key opinion leader outreach, consumer events, community outreach and traditional media relations.

22nd August 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Beyond the event
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...